Management of mould pneumonia in resource-limited settings in Asia: A Delphi-based consensus statement by the Asia

Methee Chayakulkeeree1, Ban Hock Tan2, Yee-Chun Chen3,4

  • 1Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10400, Thailand.

Medical Mycology
|November 18, 2025
PubMed

Insights

Mould pneumonia is a growing threat in Asia. This study developed consensus statements for its diagnosis and management, especially in resource-limited Asian settings.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Mould pneumonia poses a significant, increasing health risk in Asia.
  • Diagnostic and treatment resources for mould pneumonia vary widely, particularly in resource-limited regions.
  • Current clinical management practices and recommendations for mould pneumonia in Asia are not well-defined.

Purpose of the Study:

  • To establish a consensus statement for the clinical management of mould pneumonia in Asia.
  • To address the specific challenges of diagnosis and treatment in resource-limited Asian settings.

Main Methods:

  • A Delphi-based methodology was employed, involving clinicians and infectious disease experts from the Asia Fungal Working Group.
  • Panelists anonymously answered questionnaires on epidemiology, diagnosis, and treatment of mould pneumonia.
  • Two rounds of anonymous voting and a five-point Likert scale were used to reach consensus on 21 statements.

Main Results:

  • Twenty-one summary statements were generated covering epidemiology, diagnosis, and treatment of mould pneumonia.
  • Twenty statements achieved a consensus of 70% or higher among the expert panelists.
  • The consensus focused on diagnosis and management strategies applicable to resource-limited settings.

Conclusions:

  • A comprehensive set of 21 consensus statements for diagnosing and managing mould pneumonia in Asia was developed.
  • These statements provide crucial guidance for clinicians, particularly in resource-limited environments.
  • The consensus addresses the increasing incidence and challenges associated with mould pneumonia in the region.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
735
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
765
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
395
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
710
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
614